Interventions to Increase Completion of Hepatitis B Vaccination in People Who Inject Drugs: A Systematic Review and Meta-analysis

Overview

Journal Open Forum Infect Dis

Specialty Infectious Diseases

Date 2020 Jan 1

PMID 31890724

Citations 15

Authors

Stacy Tressler

Ruchi Bhandari

Affiliations

Soon will be listed here.

Abstract

Increases in opioid misuse and injection drug use have resulted in a rise in acute cases of hepatitis B. We conducted a systematic review and meta-analysis of randomized studies to determine the effect (pooled odds ratio) of interventions to increase hepatitis B vaccination completion in people who inject drugs (PWID). Odds ratios from the included studies were combined to create a pooled odds ratio (OR) using the Inverse Heterogeneity Model. Eleven studies met the eligibility criterion of having a randomized intervention to increase hepatitis B virus vaccination completion among PWID. The odds of vaccine completion in the intervention group were greater than in the control/comparison group (pooled OR, 2.53; 95% confidence interval [CI], 1.07-5.99). Subgroup analysis indicated that financial incentives were most effective (OR, 7.01; 95% CI, 2.88-17.06), followed by accelerated vaccine schedules (OR, 1.90; 95% CI, 1.14-3.14). Interventions using financial incentives and accelerated vaccine schedules are moderately effective at increasing hepatitis B vaccination completion in PWID.

Citing Articles

Comparison of Serological Immune Response to Hepatitis B Vaccine Following Rapid or Standard Regimen in People Who Inject Drugs.

Rajkumar N, Mishra A, Khumukcham L, Katiyar H, Thangjam D, Singh R J Clin Exp Hepatol. 2025; 15(3):102501.

PMID: 39975859 PMC: 11833630. DOI: 10.1016/j.jceh.2025.102501.

Identifying barriers to hepatitis B and delta screening, prevention, and linkage to care among people who use drugs in Philadelphia, Pennsylvania, USA.

Zovich B, Freeland C, Moore H, Sapp K, Qureshi A, Jessop A Harm Reduct J. 2024; 21(1):199.

PMID: 39548537 PMC: 11566396. DOI: 10.1186/s12954-024-01117-4.

Self-reported lifetime Hepatitis B virus testing, and vaccination uptake among people who inject drugs in Iran: a nationwide study in 2020.

Bazrafshani M, Mehmandoost S, Tavakoli F, Shahesmaeili A, Ghalekhani N, Sharafi H BMC Public Health. 2024; 24(1):3156.

PMID: 39538214 PMC: 11562248. DOI: 10.1186/s12889-024-20646-y.

COVID-19 vaccine implementation at a syringe services program: experiences of frontline staff.

Plesons M, Soto Sugar S, Chimbaru R, McDonald G, Friedman L, Thompson Jr E BMC Health Serv Res. 2024; 24(1):1260.

PMID: 39427164 PMC: 11490171. DOI: 10.1186/s12913-024-11691-9.

Dismantling Barriers to Hepatitis B and Delta Screening, Prevention, and Linkage to Care among the PWUD Community in Philadelphia.

Zovich B, Freeland C, Moore H, Sapp K, Qureshi A, Holbert R Viruses. 2024; 16(4).

PMID: 38675969 PMC: 11054430. DOI: 10.3390/v16040628.

References

Seal K, Kral A, Lorvick J, McNees A, Gee L, Edlin B . A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users. Drug Alcohol Depend. 2003; 71(2):127-31. DOI: 10.1016/s0376-8716(03)00074-7. View

Christensen P, Fisker N, Krarup H, Liebert E, Jaroslavtsev N, Christensen K . Hepatitis B vaccination in prison with a 3-week schedule is more efficient than the standard 6-month schedule. Vaccine. 2004; 22(29-30):3897-901. DOI: 10.1016/j.vaccine.2004.04.011. View

Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward J . Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2018; 67(1):1-31. PMC: 5837403. DOI: 10.15585/mmwr.rr6701a1. View

Tran T, Grimes C, Lai D, Troisi C, Hwang L . Effect of age and frequency of injections on immune response to hepatitis B vaccination in drug users. Vaccine. 2011; 30(2):342-9. PMC: 3246115. DOI: 10.1016/j.vaccine.2011.10.084. View

Hu Y, Grau L, Scott G, Seal K, Marshall P, Singer M . Economic evaluation of delivering hepatitis B vaccine to injection drug users. Am J Prev Med. 2008; 35(1):25-32. PMC: 2483306. DOI: 10.1016/j.amepre.2008.03.028. View

Topp L, Day C, Wand H, Deacon R, van Beek I, Haber P . A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia. Prev Med. 2013; 57(4):297-303. DOI: 10.1016/j.ypmed.2013.04.013. View

Hwang L, Grimes C, Tran T, Clark A, Xia R, Lai D . Accelerated hepatitis B vaccination schedule among drug users: a randomized controlled trial. J Infect Dis. 2010; 202(10):1500-9. PMC: 2957504. DOI: 10.1086/656776. View

Nyamathi A, Salem B, Zhang S, Farabee D, Hall B, Khalilifard F . Nursing case management, peer coaching, and hepatitis a and B vaccine completion among homeless men recently released on parole: randomized clinical trial. Nurs Res. 2015; 64(3):177-89. PMC: 4418035. DOI: 10.1097/NNR.0000000000000083. View

Nyamathi A, Sinha K, Greengold B, Cohen A, Marfisee M . Predictors of HAV/HBV vaccination completion among methadone maintenance clients. Res Nurs Health. 2010; 33(2):120-32. PMC: 3253736. DOI: 10.1002/nur.20371. View

10.

Weaver T, Metrebian N, Hellier J, Pilling S, Charles V, Little N . Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial. Lancet. 2014; 384(9938):153-63. DOI: 10.1016/S0140-6736(14)60196-3. View

11.

. A Two-Dose Hepatitis B Vaccine for Adults (Heplisav-B). JAMA. 2018; 319(8):822-823. DOI: 10.1001/jama.2018.1097. View

12.

Asli A, Moghadami M, Zamiri N, Tolide-Ei H, Heydari S, Alavian S . Vaccination against hepatitis B among prisoners in Iran: accelerated vs. classic vaccination. Health Policy. 2011; 100(2-3):297-304. DOI: 10.1016/j.healthpol.2010.12.007. View

13.

Zibbell J, Asher A, Patel R, Kupronis B, Iqbal K, Ward J . Increases in Acute Hepatitis C Virus Infection Related to a Growing Opioid Epidemic and Associated Injection Drug Use, United States, 2004 to 2014. Am J Public Health. 2017; 108(2):175-181. PMC: 5846578. DOI: 10.2105/AJPH.2017.304132. View

14.

Nyamathi A, Sinha K, Saab S, Marfisee M, Greengold B, Leake B . Feasibility of completing an accelerated vaccine series for homeless adults. J Viral Hepat. 2009; 16(9):666-73. PMC: 3780569. DOI: 10.1111/j.1365-2893.2009.01114.x. View

15.

Harris A, Iqbal K, Schillie S, Britton J, Kainer M, Tressler S . Increases in Acute Hepatitis B Virus Infections - Kentucky, Tennessee, and West Virginia, 2006-2013. MMWR Morb Mortal Wkly Rep. 2016; 65(3):47-50. DOI: 10.15585/mmwr.mm6503a2. View

16.

Bowman S, Grau L, Singer M, Scott G, Heimer R . Factors associated with hepatitis B vaccine series completion in a randomized trial for injection drug users reached through syringe exchange programs in three US cities. BMC Public Health. 2014; 14:820. PMC: 4138371. DOI: 10.1186/1471-2458-14-820. View

17.

Bridges C, Watson T, Nelson N, Chavez-Torres M, Fineis P, Ntiri-Reid B . Challenges with hepatitis B vaccination of high risk adults - A pilot program. Vaccine. 2019; 37(35):5111-5120. PMC: 8819536. DOI: 10.1016/j.vaccine.2019.05.089. View

18.

Walsh N, Verster A, Rodolph M, Akl E . WHO guidance on the prevention of viral hepatitis B and C among people who inject drugs. Int J Drug Policy. 2014; 25(3):363-71. DOI: 10.1016/j.drugpo.2014.01.009. View

19.

Masson C, Delucchi K, McKnight C, Hettema J, Khalili M, Min A . A randomized trial of a hepatitis care coordination model in methadone maintenance treatment. Am J Public Health. 2013; 103(10):e81-8. PMC: 3853128. DOI: 10.2105/AJPH.2013.301458. View